2021
DOI: 10.7759/cureus.13314
|View full text |Cite
|
Sign up to set email alerts
|

The Rare Diagnosis of Synchronous Breast and Colonic Cancers: A Case Report and Review of Literature

Abstract: Any two or more primary malignant tumors, in which each tumor is not an extension, recurrence, or metastasis of the other lesion, are defined or described as multiple primary malignant neoplasms (MPMN). These tumors are increasingly diagnosed despite their rare occurrence rate. The term synchronous tumors is applied if two different tumors originating in the same patient are detected at the same time or within six months; if the second tumor is detected beyond six months, it is called metachronous. Aetiologica… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 18 publications
(21 reference statements)
0
1
0
Order By: Relevance
“…Breast cancer was found in 23% and colorectal cancer was found in 25.6% of female with multiple cancers [ 13 ]. Etiology of developing multiple cancers in the same individual could be explained by 1) familial cancer syndrome or genetic susceptibility 2) exposure to common pathogen such as alcohol and tobacco 3) effect of previous cancer treatment [ 14 ]. Other possibility is that the longer survival after the first cancer treatment leads to another probability of developing the second primary cancer [ 15 ].…”
Section: Discussionmentioning
confidence: 99%
“…Breast cancer was found in 23% and colorectal cancer was found in 25.6% of female with multiple cancers [ 13 ]. Etiology of developing multiple cancers in the same individual could be explained by 1) familial cancer syndrome or genetic susceptibility 2) exposure to common pathogen such as alcohol and tobacco 3) effect of previous cancer treatment [ 14 ]. Other possibility is that the longer survival after the first cancer treatment leads to another probability of developing the second primary cancer [ 15 ].…”
Section: Discussionmentioning
confidence: 99%